Optical Coherence Tomography Angiography of Iris Nevus: A Case Report by Allegrini, D. et al.
              
City, University of London Institutional Repository
Citation: Allegrini, D., Montesano, G. and Pece, A. (2016). Optical Coherence 
Tomography Angiography of Iris Nevus: A Case Report. Case Reports in Ophthalmology, 
7(3), pp. 173-178. doi: 10.1159/000450572 
This is the published version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  http://openaccess.city.ac.uk/21811/
Link to published version: http://dx.doi.org/10.1159/000450572
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
  
Case Rep Ophthalmol 2016;7:172–178 
DOI: 10.1159/000450572 
Published online: October 10, 2016 
© 2016 The Author(s) 
Published by S. Karger AG, Basel 
www.karger.com/cop 
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 
International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes requires written permission. 
 
 
           
 
 Davide Allegrini, MD 
Department of Ophthalmology, Melegnano Hospital 
Via Pandina 1 






Optical Coherence Tomography 
Angiography of Iris Nevus: A Case 
Report 
 
Davide Allegrinia    Giovanni Montesanob    Alfredo Pecea     
a
Department of Ophthalmology, Melegnano Hospital, Milan, Italy; 
b
Eye Clinic, San Paolo 
Hospital, University of Milan, Milan, Italy 
Keywords 
Iris optical coherence tomography angiography · Iris nevus vasculature · Iris fluorescein 
angiography 
Abstract 
Iris nevus is common: 6% of patients with suspected iris melanoma have lesions other than 
melanoma, and 36% of them are nevi. Iris nevus turns into melanoma in approximately 8% of 
cases at a mean of 15 years. This case report provides the first description of an iris tumor 
examined with iris optical coherence tomography angiography (OCTA) compared to iris fluo-
rescein angiography (IFA). A 60-year-old man with a diagnosis of iris nevus in the left eye 
was referred to our department for IFA and iris OCTA. The iris vasculature in IFA was visible 
only in the early phases, but not clearly. OCTA, however, gave visualization of the vascular 
network and very precisely defined the vessels of the whole lesion, except for the pupillary 
portion, which was masked by superficial pigment accumulations. IFA and iris OCTA can add 
information about the vascular architecture compared to slit-lamp biomicroscopy, ultrasound 
biomicroscopy, and anterior-segment OCT. However, IFA is time-consuming and invasive and 
can – very occasionally – cause serious adverse reactions. In contrast, OCTA defines the tex-
ture of the iris vasculature better. In conclusion, OCTA is a new method, easy to execute, 
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needing no dye injection, and provides useful information on the vascular network of iris 
lesions. It could therefore be helpful in the diagnosis and follow-up of these lesions. 
 © 2016 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Iris nevus is common: a clinical study suggested that these nevi are present in 9% of a 
general population [1]. A recent investigation on 3,610 patients with iris tumors found that 
iris nevus was the most common condition including 25% of all iris lesions in children, 36% 
in young adults, and 47% in middle-aged and senior adults [2]. Several lesions of the iris may 
look clinically like melanoma. Shields et al. [3] studied 200 patients referred for suspected 
iris melanoma, and 158 (76%) were found to have lesions other than melanoma; these are 
termed pseudomelanomas. The most common pseudomelanomas included iris cyst (38%) 
and iris nevus (31%). Iris nevus turns into melanoma in approximately 8% of cases at an 
average of 15 years [4]. 
Iris fluorescein angiography (IFA) can be helpful in establishing the malignancy of iris 
tumors and in their diagnosis and follow-up. Unlike for ultrasound biomicroscopy (UBM) 
and anterior-segment optical coherence tomography (ASOCT) [5], there are no recent stud-
ies on the utility of IFA in the evaluation of iris nevi. In the past, studies on IFA have given 
conflicting results about its effective diagnostic role for this type of lesion. However, the re-
cent development of OCT angiography (OCTA) allows visualization of the capillary retinal 
layers for the construction of microvascular flow maps. This procedure, which does not need 
sodium fluorescein dye injection, can also be used to study iris vessels. This case report of-
fers the first description of an iris tumor vasculature examined with OCTA compared to IFA. 
Case Report 
A 60-year-old man with suspected iris nevus in the left eye was referred to our depart-
ment for IFA and iris OCTA. The patient was being followed at another center, which had 
already performed (1) a complete ophthalmic evaluation [anterior segment (AS), intraocular 
pressure, and fundus oculi]; (2) a photography of the AS; (3) UBM, and (4) ASOCT. The diag-
nosis was iris nevus. All these examinations had been repeated every 6 months for the first 2 
years, then annually. At the last eye check, the lesion had been stable for 10 years. 
For IFA, we used the digital fluorescein angiogram instrument (TRC-50DX; Topcon, 
Itabashi-ku, Tokyo, Japan) with the focus set on +30.00 D. Angiographic images were cap-
tured after slow injection of 3 ml of fluorescein dye, and images were taken at 30 s and  
3 min. The OCTA examination was done with the AngioVue system (Optovue Inc., Fremont, 
Calif., USA). This instrument operates at approximately 840 nm wavelength and 70,000 A-
scans per second to acquire OCTA volumes consisting of 2 repeated B-scans from 304 se-
quential, uniformly spaced locations. All scans were automatically processed by the internal 
software to reduce motion artefacts (ReVue V.2014.2.0.15). The examination was done in 
AngioRetina mode, but with the AS optical adaptor lens and without autofocus, manually 
adjusting the xyz-axes to bring the iris vessels into focus. OCTA scans were captured in both 
eyes, always by the same operator. The images were acquired in 3 × 3 and 6 × 6 cubes. 
At our ophthalmological evaluation, the patient presented s best-corrected visual acuity 
of 20/20 and an intraocular pressure of 16 mm Hg in both eyes. The AS photography showed 
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a blue iris with a hyperpigmented lesion measuring 2.60 × 2.26 mm, localized in the inferior 
nasal sector, with slight deformation of the pupil; the pupillary portion was the most pig-
mented area (about one third of the entire nevus surface) (fig. 1). IFA indicated early fluo-
rescence in the tumor and a tendency for dye to leak late, progressively covering the nevus 
vasculature. The largest pigmented area of the pupillary nevus portion caused an irregular 
hypofluorescent zone in the angiogram, which persisted into the late phases. The vascular 
network was not clearly observable, and then only at the early time points. It seemed irregu-
lar but was not clearly visible in detail (fig. 2). 
Iris OCTA gave a better visualization of the nevus vascular network, and in the case de-
scribed, it was clearly observable on the entire lesion except for the pupillary portion, which 
was masked by superficial pigment accumulation. The nevus vasculature appeared anarchic, 
in marked contrast to the linear course of the iris vessels (fig. 3). Segmentation was manually 
corrected by moving the top and bottom layers to include the whole region of interest. Al-
though this meant that part of the apex of the nevus was not included, no OCTA data were 
excluded in the projection depicted in figure 3. Iris OCT scans were taken upside down to 
enhance the signal from deeper layers of the nevus, as is sometimes done in enhanced depth 
imaging [6]. 
In our eye check, the features and size of the lesion appeared stable. This is compatible 
with a diagnosis of iris nevus. However, the patient had not previously been examined by 
both IFA and OCTA, so we recommended repeating these tests after about 6 months to as-
sess any changes in the leakage and vascular network. 
Discussion 
Iris nevus carries a low risk of progression to melanoma. In a recent series of 1,611 eyes 
with iris nevus, Shields et al. [4] found 6 predictive clinical factors for growth (A–F): AGE 
young, Blood (hyphema), Clock hour inferior, Diffuse (involving entire iris surface) configu-
ration, Ectropion uveae, and Feathery margins. Tumor basal diameter and thickness were 
measured in millimeters by slit-lamp biomicroscopy and, when available, UBM and ASOCT 
[4]. For the A–F parameters, the slit lamp, UBM, and ASOCT are useful in the follow-up to 
check the growth of the iris nevus. They provide information on the size, infiltration, and 
localization of iris tumors [5] but do not show the vascular architecture. 
It is not easy to clinically establish a reliable diagnosis of pigmented iris tumors; howev-
er, the iris lesion vasculature may show alterations characteristic of malignant forms, so this 
is useful for a correct diagnosis in case of a pigmented neoformation of the iris [7]. IFA can 
show the vascular network but only with intravenous sodium fluorescein dye; in addition, it 
is time-consuming and invasive and can – very occasionally – cause serious adverse reac-
tions. These aspects make it unsuitable for periodic checks. In contrast, the iris vasculariza-
tion can be studied with OCTA without the need for fluorescein. 
IFA, unlike OCTA, depicts blood vessel leakage. If early, this can impede visualization of 
the iris vessels. Although the importance of vascular leakage in iris tumors is debated, there 
are reports that it may be indicative of malignancy [8], especially if early or profuse [9–12], 
though others maintain that it is associated with both benign and malignant tumors [10,  
11, 13]. 
Both IFA and iris OCTA depict the vascular network of the neoformation and the effects 
of its growth on surrounding tissues. These features are very important, as in fact some au-
thors believe that a geometric and organized vascular picture may be associated with benign 
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lesions [11, 12], and others maintain that a disorganized, irregular tumor vasculature can be 
a sign of malignancy [9, 11, 13]. However, in our patient, the nevus vascularization, although 
partially masked by pigment in the pupillary portion, was more clearly visible with OCTA 
than with IFA. The vascular nevus network was not clearly visible with IFA because it was 
masked by rapid loss of dye from the vessels. Instead, with OCTA, it could be seen better on 
the entire lesion – except for the part covered by superficial pigment – because, as no dye is 
used, there is no interference due to early leakage (fig. 2, 3). 
In conclusion, we believe that OCTA examination of the iris vasculature may be useful 
both for the diagnosis and follow-up to evaluate the tumor edges and to observe the vascular 
structure of the tumor without dye injection. Further studies and experience will be neces-
sary to confirm this preliminary report. 
Conclusion 
The case reported provides the first OCTA description of an iris nevus. This instrument 
has already been employed to study the retina, and we reprogrammed it for the study of iris 
lesions. The prognostic value of vascular leakage in iris tumors is not clear, but details of the 
vascular network could provide additional information in relation to the A–F criteria regard-
ing malignancy or benignity of a pigmented iris tumor. Therefore, iris OCTA, offering ease of 
execution and safety, could be helpful in the follow-up of iris lesions together with slit-lamp 
biomicroscopy, UBM, and ASOCT to check on the progression of pigmented iris tumors. 
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Fig. 2. IFA of the left eye: 30 s (a) and 3 min (b) after injection of fluorescein dye. 
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Fig. 3. Iris OCT and OCTA of the left eye: 3 × 3 (a) and 6 × 6 (b) cubes. 
 
